Oct 14, 2025 01:40AM

Aug 13, 2025 05:52AM

Aug 8, 2025 05:49AM

Jun 26, 2025 02:00AM

Jun 17, 2025 11:14AM

May 27, 2025 04:30AM

Oct 29, 2024 12:00AM RemeGen Announces the Acceptance of the Marketing Application of Telitaccept for the Treatment of Myasthenia Gravis in China

Aug 6, 2024 05:00AM

May 10, 2024 04:24AM

Apr 2, 2024 11:11PM

Jan 12, 2024 05:13AM

Sep 26, 2023 09:30PM

Feb 27, 2023 08:07PM

Dec 12, 2022 11:30PM RemeGen's RC118 for Injection Targeting Claudin 18.2 in Patients with Gastric and Pancreatic Cancers Granted Two Orphan Drug Designations by U.S. FDA

Oct 12, 2022 08:00PM

May 23, 2022 10:27PM

324,158 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All